MAM
mCaffeine partners with Clinikk to provide free medical facilities for the employees and their families in the current COVID-19 pandemic
MUMBAI: mCaffeine, India’s fastest growing caffeine infused personal care brand has partnered with Clinikk, the healthcare startup to provide free medical facilities for the employees and their families in this current 21 day lockdown due to COVID-19 pandemic.
This association will help mCaffeine employees and their families to get access to 24*7 medical support and unlimited and free consultations with doctors on call through their helpline number. All doctors are qualified (MBBS or specialization), with extensive training in telemedicine. Post the consultation; a signed prescription will be shared on SMS/WhatsApp & the Clinikk App. If a further diagnosis requires lab tests, the sample will get collected at home. Employees can also order medicines online and can get benefited from discounts.
Tarun Sharma, co-founder & CEO, mCaffiene said, “The need of the hour is to extend maximum possible support to your employees and their families. Besides assuring the job and financial security, it is pertinent to take care of their physical and mental well being. In a lockdown scenario when one cannot step out of their home more so because of the spread of a highly contagious virus, its our responsibility to take care of their health needs. We don’t want them to compromise or neglect themselves. In such a panic scenario one may not know whom to approach or where to go.
While all employees are working from home; we want them to be tension free regarding any health problems of themselves and their families by providing them door-step medical facilities. Clinikk app which gives a one-stop solution will provide the much required ease and convenience. Employee wellness is prime at mCaffeine. More than 400 people will benefit from this association.’’
Bengaluru based health tech startup, Clinikk is revolutionizing the approach to healthcare in India, by building a one-stop solution for all healthcare needs at just one-phone-call-away. The ability of Clinikk is to diagnose and treat certain ailments using remote technology instead of person-to-person contact, thereby creating ease of access to medical care.
“At Clinikk we believe in becoming the first point of contact for any medical need that a family might have. Being there for them 24*7 ensures that we are able to detect any medical problem proactively at its onset and make necessary intervention before it manifests itself as a more serious issue", Said, Bhavjot Kaur, co-founder of Clinikk Healthcare.
Apart from doctor consultations, if any medical information is required for eg. partner hospitals, it can be directed to the Health Assistants, who provide relevant, accurate information. Based on seasonal change, medical history etc. – Clinikk provides personalized awareness building information through WhatsApp, SMS and IVR calls. The languages currently supported are; English, Hindi, Kannada, Tamil, Telugu, Malayalam, Bangla, Assamese, Marathi.
Brands
Maharashtra panel orders Lodha to refund Rs 5 crore to homebuyers
Consumer court flags unfair practices in long-running property dispute case
MUMBAI: In a sharp rebuke to one of India’s biggest real estate players, the Maharashtra State Consumer Disputes Redressal Commission has directed Macrotech Developers to refund nearly Rs 5 crore to a senior citizen couple, Uttam and Anindita Chatterjee. The ruling, delivered on March 13, 2026, calls out the developer for “deficiency in service” and “unfair trade practices”, bringing closure to a dispute that has stretched over a decade.
The case traces back to 2015, when the couple booked a 3-BHK flat at World Towers in Lower Parel for Rs 12.22 crore, with possession promised within a year. What followed was a series of changes that complicated matters. After deciding to exit the project, they were persuaded to shift to a 4-BHK in another development priced at Rs 8 crore, with delivery scheduled for 2018. However, within months, the price was allegedly increased to Rs 10 crore. After demonetisation reshaped the market, similar flats were reportedly being offered at lower prices, but the couple were not given the benefit.
Despite paying over Rs 2.83 crore, the couple neither received possession nor clarity. Instead, in 2018, the developer unilaterally cancelled the booking, retained part of the amount as earnest money, and argued that the buyers were investors rather than consumers. The commission rejected this claim, observing that casual references to “investment” do not take away consumer rights when the purchase intent is residential.
The bench also held that the developer could not penalise buyers for payment delays while failing to meet its own delivery commitments. It noted the lack of formal documentation for revised terms and termed the prolonged retention of funds without delivering a home as exploitative.
As part of its order, the commission directed the developer to refund Rs 2.83 crore paid by the couple, along with interest at 10 per cent per annum, amounting to around Rs 2.12 crore. In addition, Rs 1 lakh has been awarded for mental agony and Rs 50,000 towards litigation costs, taking the total payout to over Rs 5 crore. The developer has been asked to comply within two months.
For now, the ruling serves as a reminder that in real estate, shifting terms and delayed promises can carry a significant cost.
